Nada Hassan Salah
1 clinical trials · Sponsor
| Record | Firm | Date |
|---|---|---|
| Upfront Treatment With Chemotherapy and Bevacizumab in Advanced Ovarian Cancer (NCT03611179) | Nada Hassan Salah | 2018-09-01 |
Track Nada Hassan Salah automatically
Every clearance here is in the API, with alerts when new ones post.